Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Prognosis of multi-lobar pneumonia in community-acquired pneumonia: a systematic review and meta-analysis.

Mannu GS, Loke YK, Curtain JP, Pelpola KN, Myint PK.

Eur J Intern Med. 2013 Dec;24(8):857-63. doi: 10.1016/j.ejim.2013.05.001. Epub 2013 Jun 6. Review.

PMID:
23747042
2.

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN.

JAMA. 1996 Jan 10;275(2):134-41.

PMID:
8531309
3.

Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis.

Cheng M, Pan ZY, Yang J, Gao YD.

Respir Care. 2014 Apr;59(4):557-63. doi: 10.4187/respcare.02758. Epub 2013 Sep 17. Review.

4.

Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis.

Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, Wood V, Hill AT.

Thorax. 2010 Oct;65(10):878-83. doi: 10.1136/thx.2009.133280. Epub 2010 Aug 20. Review.

PMID:
20729231
5.

Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.

Lee JH, Chung HJ, Kim K, Jo YH, Rhee JE, Kim YJ, Kang KW.

Am J Emerg Med. 2013 Jan;31(1):72-9. doi: 10.1016/j.ajem.2012.06.004. Epub 2012 Aug 3.

PMID:
22867824
6.

Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia.

Akram AR, Chalmers JD, Hill AT.

QJM. 2011 Oct;104(10):871-9. doi: 10.1093/qjmed/hcr088. Epub 2011 Jul 18.

PMID:
21768166
7.

Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.

Cilli A, Erdem H, Karakurt Z, Turkan H, Yazicioglu-Mocin O, Adiguzel N, Gungor G, Bilge U, Tasci C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Samur AA, Tomak Y, Inan A, Karaboga B, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozcengiz D, Karakas A, Savasci U, Ozgen-Alpaydın A, Kilic E, Elaldi N, Bilgic H.

J Crit Care. 2013 Dec;28(6):975-9. doi: 10.1016/j.jcrc.2013.08.004. Epub 2013 Sep 24.

PMID:
24075301
8.

COPD is associated with increased mortality in patients with community-acquired pneumonia.

Restrepo MI, Mortensen EM, Pugh JA, Anzueto A.

Eur Respir J. 2006 Aug;28(2):346-51. Epub 2006 Apr 12.

9.

Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.

Yang Y, Xu F, Shi LY, Diao R, Cheng YS, Chen XY, Jing JY, Wang XD, Shen HH.

Chin Med J (Engl). 2012 Feb;125(4):639-45.

PMID:
22490488
10.

Risk prediction models for mortality in community-acquired pneumonia: a systematic review.

Kwok CS, Loke YK, Woo K, Myint PK.

Biomed Res Int. 2013;2013:504136. doi: 10.1155/2013/504136. Epub 2013 Oct 21.

11.

Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Scally C, Hill AT.

Ann Emerg Med. 2009 May;53(5):633-8. doi: 10.1016/j.annemergmed.2008.12.022. Epub 2009 Feb 7.

PMID:
19201061
12.

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor.

Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Génin R, Yvin JL.

Eur Respir J. 2004 Nov;24(5):779-85.

13.

Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis.

Sligl WI, Asadi L, Eurich DT, Tjosvold L, Marrie TJ, Majumdar SR.

Crit Care Med. 2014 Feb;42(2):420-32. doi: 10.1097/CCM.0b013e3182a66b9b. Review.

PMID:
24158175
14.
15.

Evaluation of the IDSA/ATS minor criteria for severe community-acquired pneumonia.

Sibila O, Mortensen EM, Redrow G, Lugo E, Laserna E, Anzueto A, Restrepo MI.

Hosp Pract (1995). 2012 Apr;40(2):158-64. doi: 10.3810/hp.2012.04.981.

PMID:
22615090
16.

Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia.

Fang WF, Yang KY, Wu CL, Yu CJ, Chen CW, Tu CY, Lin MC.

Crit Care. 2011;15(1):R32. doi: 10.1186/cc9979. Epub 2011 Jan 19.

17.

Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies.

Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, Fergusson DA.

PLoS Med. 2011 Jun;8(6):e1001048. doi: 10.1371/journal.pmed.1001048. Epub 2011 Jun 28. Review.

18.

Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.

Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.

J Crit Care. 2011 Jun;26(3):287-94. doi: 10.1016/j.jcrc.2010.10.007. Epub 2010 Dec 3.

PMID:
21129911
19.
20.

Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.

Loke YK, Kwok CS, Niruban A, Myint PK.

Thorax. 2010 Oct;65(10):884-90. doi: 10.1136/thx.2009.134072. Epub 2010 Aug 20. Review.

PMID:
20729235

Supplemental Content

Support Center